Fortis Healthcare

Fortis Healthcare partners with Excelity for payroll and benefits administration

Fortis Healthcare partners with Excelity for payroll and benefits administration

New Delhi [India], Feb. 21 : Excelity Global, India's largest provider of payroll administration, benefits and human capital management, announced its collaboration with Fortis Healthcare, on Monday.

"We take pride that Fortis has chosen Excelity as its partner of choice to manage their payroll and benefits operations. Organisations today are looking to streamline their payroll and benefits administration process while gaining process efficiencies and Excelity has been instrumental in doing this on a continuous basis," said Sumit Sabharwal, CEO (Managed Services), Excelity Global.

As part of this strategic engagement, Excelity will leverage its HR outsourcing experience to manage payroll and benefits for over 22,000 colleagues within Fortis Healthcare and other group companies.

Two new medical facilities in Bengaluru by Fortis Healthcare

Two new medical facilities in Bengaluru by Fortis HealthcareA top official has stated that Fortis Healthcare BSE 1.13 % will include two restorative offices in Bengaluru, including what added up to 280 beds. It means to twofold in size to 10,000 couches in advancing five years.

Fortis Healthcare reports Rs 32cr Q2 net profit

Fortis Healthcare reports Rs 32cr Q2 net profitFortis Healthcare Ltd on Tuesday announced a net profit of Rs 32.06 crore for the quarter ended September 30, as against a loss of Rs 28.43 crore in the corresponding three-month period of last year.

Fortis' net profit increased despite a considerable decline in its net sales. During the July-September quarter of current fiscal, the company's net sales slipped to Rs 1,281 crore, from Rs 1,493 crore in the year-ago period. The healthcare company attributed the impressive quarterly profit to its focus on the India business.

Fortis Healthcare shares jump on plan to sell stake in Hong Kong unit

Fortis HealthcareFortis Healthcare shares enjoyed a considerable increase in their market value after the company on Monday announced its decision to sell its stake in Hong Kong-based Quality Healthcare (QH) to Bupa.

Fortis Healthcare International Pte Ltd, a division of Fortis Healthcare Ltd, announced that it would offload its entire stake in QH's holding firm Altai Investments Ltd to Bupa for $355 million.

Fortis launches 'next-generation' hospital in Gurgaon

Fortis-Healthcare1New Delhi, April 30 : Fortis Healthcare Limited, a chain of private healthcare providers, Tuesday launched its flagship "next-generation" hospital, the Fortis Memorial Research Institute (FMRI) in Gurgaon, an official said here Tuesday.

The multi-speciality quaternary care hospital will have a capacity of 1,000 beds. In the first phase, the hospital will function with 450 beds.

FMRI aims to bring the next generation of super-specialization in oncology, trauma and pediatric care, with embedded centres at hospital in neurosciences, minimal access surgery, cardiac sciences and orthopedics.

Fortis shares jump on announcement of Dental stake sale for A$270 million

Fortis shares jump on announcement of Dental stake sale for A$270 million Stock in Fortis Healthcare International gained as much as 7.5 per cent in early trading on Monday to hit its 52-week high of Rs 119.50 a share after the integrated healthcare delivery provider announced its decision to sell its majority stake in Dental Corporation Holding.

Fortis Healthcare on Sunday announced that it would sell its 64 per cent stake in Dental Corporation Holdings, Australia, to the UK-based health insurance & healthcare firm Bupa for A$270 million (nearly Rs 1,550 crore).

Religare Health Trust aiming to raise $417.9 million through Singapore IPO

Religare Health Trust aiming to raise $417.9 million through Singapore IPOReligare Health Trust of the Indian hospital chain operator Fortis Healthcare, is aiming to raise about $417.9 million through an Initial Public Offering at the Singapore Stock Exchange.

Religare will offer 567.46 million shares and it has set an IPO price of S$0.90 per share, according to the final prospectus filed by the company with the Monetary Authority of Singapore. The company will offer 555.46 million shares to institutional investors in Singapore and abroad and the remaining 12 million to the general public.

Buy Fortis Healthcare To Achieve Target Of Rs 180

Buy Fortis Healthcare To Achieve Target Of Rs 180Technical analyst Kunal Saraogi is bullish on Fortis Healthcare (India) Limited and has maintained 'buy' rating on the stock with a target of Rs 175-180.

Mr. Saraogi said that the investors can buy the stock above Rs 154.

The stock of the company, on March 24, ended at Rs 150.20 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 185.70 and a low of Rs 129 on BSE.

Current EPS & P/E ratio stood at 3.01 and 49.83 respectively.

Fortis Healthcare Has Resistance At Rs 155

Fortis Healthcare Has Resistance At Rs 155Technical analyst MB Singh has maintained 'buy' rating on Fortis Healthcare Limited stock with a stop loss of Rs 130.

According to analyst, the investors can buy the stock on dips.

Mr. Singh said that Fortis Healthcare stock has resistance at Rs 155.

The stock of the company, on March 10, closed at Rs 151.35 on the Bombay Stock Exchange (BSE).

Current EPS & P/E ratio stood at 3.01 and 50.43 respectively.

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 129 on BSE.

Buy Fortis Healthcare With Stop Loss Of Rs 148

Buy Fortis Healthcare With Stop Loss Of Rs 148Technical analyst Amrut Deshmuk of Way2Wealth has maintained 'buy' rating on at Rs 154 Limited stock to achieve a target of Rs 164.

According to analyst, the investors can buy the stock at Rs 154 with a stop loss of Rs 148.

The stock of the company, on March 04, closed at Rs 150.15 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 129 on BSE.

Current EPS & P/E ratio stood at 3.01 and 50.18 respectively.

Land assets right to be transferred to REIT by Fortis

Land assets right to be transferred to REIT by FortisFortis healthcare, the second largest hospital chain in India is said to be evaluating a plan wherein they are going to transfer all the land assets to a real estate investment trust (REIT). The money thus obtained is going to be used for the purpose of expansion.

Fortis Healthcare Intraday Buy Call

Fortis Healthcare Intraday Buy CallTechnical analyst Kunal Saraogi has maintained 'buy' rating on Fortis Healthcare Limited stock with a target of Rs 145.

According to analyst, the stock can be purchased with a stop loss of Rs 132.

The stock of the company, on February 01, closed at Rs 134.35 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 129 on BSE.

Current EPS & P/E ratio stood at 2.70 and 51.34 respectively.

Anaesthesia regulations aimed at better offering for treatment

Fortis-healthcareThe department of anaesthesia, pain relief and critical care at Fortis Hospitals released "Protocols in Anaesthesia", which aims to normalize the anaesthesia procedure to proffer a better quality medical result and further offer a superior patient safety pre and post surgery.

Fortis extends its reach to Speciality Medical Centres

Fortis-HealthcareFortis Healthcare pronounced its foray into Speciality Medical Centres, which will further concentrate on the cure of metabolic diseases, comprising of diabetes and hormonal disorders.

These standalone centres will aid in expansion of Fortis's reach and capacity to attain the increased demands for quality healthcare services, Fortis Healthcare explained through a statement.

Hold Fortis Healthcare With Target Of Rs 250

Hold Fortis Healthcare With Target Of Rs 250Technical analyst Rajesh Tambe of Sunchan Securities has maintained 'hold' rating on Fortis Healthcare Limited stock to achieve a long term target.

The analyst said that the stock can be purchased with a target of Rs 250.

Today, the stock of the company opened at Rs 148.80 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 113 on BSE.

Current EPS & P/E ratio stood at 2.70 and 55.35 respectively.

Short Term Buy Call For Fortis Healthcare

Short Term Buy Call For Fortis HealthcareTechnical analyst Anil Singhvi is bullish on Fortis Healthcare Ltd and has recommended 'buy' rating on the stock with a target of Rs 200.

According to analyst, the interested investors can buy the stock with a stop loss of Rs 150.

Mr. Singhvi added that the investors can achieve the said target within a period of 30-45 days.

The stock of the company, on Nov 22, closed at Rs 152.15 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 104 on BSE.

Buy Fortis Healthcare With Stop Loss Of Rs 165

Buy Fortis Healthcare With Stop Loss Of Rs 165Technical analyst Manoj Sachdeva of Hem Securities has maintained 'buy' rating on Fortis Healthcare stock with a target of Rs 182.

According to analyst, the interested investors can buy the stock at Rs 169 with stop loss of Rs 165.

Mr. Sachdeva added that the said target can be achieved within 3-4 trading sessions.

Today, the stock of the company opened at Rs 168.40 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 104 on BSE.

Fortis Health bags another target

Fortis Health bags another targetThere is no denying that since the day the Singh brothers have moved on from Ranbaxy, they have been very aggressive in setting the other subsidiaries.

In fact, Fortis has been one of the names that have been one of the most aggressive companies from the past couple of years.

It is to be mentioned here that the shares of the company clocked an intraday high of Rs 176.95 and an intraday low of Rs 173.20 while the shares were up 2.72% at Rs. 175.75 at 9 AM. The company has recently said that it has bagged the health care operations of the HK based co Quality Healthcare Asia for Rs 882 crore.

Buy Fortis Healthcare With Target Of Rs 180

Buy Fortis Healthcare With Target Of Rs 180Stock market analyst Hitesh Chotalia has maintained 'hold' rating on Fortis Healthcare Ltd stock with a target of Rs 180.

According to analyst, the interested investors can buy the stock with a strict stop loss of Rs 164.

The stock of the company, on Sep 20, closed at Rs 167.40 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 187.50 and a low of Rs 99.10 on BSE.

Current EPS & P/E ratio stood at 1.50 and 113.77 respectively.

Fortis Healthcare Q1 loss at Rs 13.41 crore

Fortis Healthcare Q1 loss at Rs 13.41 croreFortis Healthcare has informed that it has suffered a net loss in the first quarter of the current fiscal year.

The leading healthcare group has announced its first quarter financial results for the fiscal year 2010-11. The company has suffered a consolidated loss of Rs 13.41 crore f for April-June quarter of the fiscal.

For the similar quarter in the last fiscal year, the company had posted a net profit of Rs 7.60 crore. Hence the quarter under review is not that satisfactory for the firm. However, it has managed to register a huge rise in its total income figure.

Syndicate content